Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy

Standard therapies versus novel therapies in Hodgkin lymphoma

(2013) A. Gallamini et al.   IMMUNOLOGY LETTERS

Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis

(2013) Nicole Skoetz et al.   LANCET ONCOLOGY

Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma

(2013) L F Porrata et al.   Blood Cancer Journal

CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma

(2012) Jonathan A Harris et al.   Diagnostic Pathology

Early interim 2-(1)fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to peripheral blood lymphocyte/monocyte ratio at diagnosis in classical Hodgkin's lymphoma

(2012) A. Romano et al.   HAEMATOLOGICA

Positron emission tomography/computed tomography surveillance in patients with lymphoma: a fox hunt?

(2012) A. Gallamini et al.   HAEMATOLOGICA

Expression of FOXP3, CD68, and CD20 at Diagnosis in the Microenvironment of Classical Hodgkin Lymphoma Is Predictive of Outcome

(2012) Paul Greaves et al.   JOURNAL OF CLINICAL ONCOLOGY

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples

(2012) Athanasios Kotsakis et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma

(2012) Bénédicte Deau et al.   LEUKEMIA & LYMPHOMA

Advances in understanding regulatory myeloid cells

(2011) Alessandra Romano et al.   CANCER BIOLOGY & THERAPY

Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma

(2011) L. F. Porrata et al.   HAEMATOLOGICA

Macrophages predict treatment outcome in Hodgkin's lymphoma

(2011) C. Steidl et al.   HAEMATOLOGICA

Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment

(2011) Christian Steidl et al.   JOURNAL OF CLINICAL ONCOLOGY

Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses

(2010) Andrea Gallamini et al.   BRITISH JOURNAL OF HAEMATOLOGY

Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer

(2010) S. Nagaraj et al.   CLINICAL CANCER RESEARCH

Myeloid-derived suppressor cell heterogeneity and subset definition

(2010) Elisa Peranzoni et al.   CURRENT OPINION IN IMMUNOLOGY

Positron emission tomography scanning: a new paradigm for the management of Hodgkin's lymphoma

(2010) A. Gallamini   HAEMATOLOGICA

Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma

(2010) P. Kamper et al.   HAEMATOLOGICA

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

(2010) Christian Steidl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma

(2010) M. K. Brimnes et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function

(2010) Thomas Condamine et al.   TRENDS IN IMMUNOLOGY

Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma

(2009) A. Avigdor et al.   ANNALS OF ONCOLOGY

Regulatory Myeloid Suppressor Cells in Health and Disease

(2009) S. Nagaraj et al.   CANCER RESEARCH

Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study

(2009) Andreas Engert et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma

(2008) Sabine Schreck et al.   HEMATOLOGICAL ONCOLOGY